Douglas Grossman - Publications

Affiliations: 
Oncological Sciences University of Utah, Salt Lake City, UT 
Area:
Molecular Biology, Oncology, Cell Biology

43 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Li C, Liu T, Liu B, Hernandez R, Facelli JC, Grossman D. A novel CDKN2A variant (p16 ) in a patient with familial and multiple primary melanomas. Pigment Cell & Melanoma Research. PMID 31001908 DOI: 10.1111/pcmr.12787  0.44
2018 Grossman D, Kumar D, Rahman H, Tyagi E, Liu T, Li C, Lu R, Lum D, Holmen SL, Maschek JA, Cox JE, VanBrocklin MW. Aspirin suppresses PGE and activates AMP kinase to inhibit melanoma cell motility, pigmentation and selective tumor growth . Cancer Prevention Research (Philadelphia, Pa.). PMID 30021726 DOI: 10.1158/1940-6207.CAPR-18-0087  0.44
2017 Tyagi E, Liu B, Li C, Liu T, Rutter J, Grossman D. Loss of p16(INK4A) stimulates aberrant mitochondrial biogenesis through a CDK4/Rb-independent pathway. Oncotarget. 8: 55848-55862. PMID 28915557 DOI: 10.18632/oncotarget.19862  0.44
2016 Cassidy PB, Liu T, Florell SR, Honeggar M, Leachman SA, Boucher KM, Grossman D. A Phase II Randomized Placebo-Controlled Trial of Oral N-acetylcysteine for Protection of Melanocytic Nevi against UV-Induced Oxidative Stress In Vivo. Cancer Prevention Research (Philadelphia, Pa.). PMID 27920018 DOI: 10.1158/1940-6207.CAPR-16-0162  0.44
2016 Truong A, Strazzulla L, March J, Boucher KM, Nelson KC, Kim CC, Grossman D. Reduction in nevus biopsies in patients monitored by total body photography. Journal of the American Academy of Dermatology. PMID 26947450 DOI: 10.1016/j.jaad.2016.02.1152  1
2015 March J, Hand M, Truong A, Grossman D. Practical application of new technologies for melanoma diagnosis: Part II. Molecular approaches. Journal of the American Academy of Dermatology. 72: 943-58; quiz 959-60. PMID 25980999 DOI: 10.1016/j.jaad.2015.02.1140  1
2015 March J, Hand M, Grossman D. Practical application of new technologies for melanoma diagnosis: Part I. Noninvasive approaches Journal of the American Academy of Dermatology. 72: 929-941. PMID 25980998 DOI: 10.1016/j.jaad.2015.02.1138  1
2015 Goodson AG, Varedi A, Hull C, Grossman D. A safe and efficient model for ultraviolet radiation-induced herpes simplex labialis. Photodermatology, Photoimmunology & Photomedicine. 31: 170-2. PMID 25684629 DOI: 10.1111/phpp.12168  1
2015 Soltani-Arabshahi R, Sweeney C, Jones B, Florell SR, Hu N, Grossman D. Predictive value of biopsy specimens suspicious for melanoma: support for 6-mm criterion in the ABCD rule. Journal of the American Academy of Dermatology. 72: 412-8. PMID 25582536 DOI: 10.1016/j.jaad.2014.11.030  1
2015 Kim CC, Swetter SM, Curiel-Lewandrowski C, Grichnik JM, Grossman D, Halpern AC, Kirkwood JM, Leachman SA, Marghoob AA, Ming ME, Nelson KC, Veledar E, Venna SS, Chen SC. Addressing the knowledge gap in clinical recommendations for management and complete excision of clinically atypical nevi/dysplastic nevi: Pigmented Lesion Subcommittee consensus statement. Jama Dermatology. 151: 212-8. PMID 25409291 DOI: 10.1001/jamadermatol.2014.2694  1
2014 Duffy KL, Truong A, Bowen GM, Andtbacka RH, Hyngstrom J, Bowles T, Grossmann K, Khong H, Hyde M, Florell SR, Bowen AR, Wada D, Grossman D. Adequacy of 5-mm surgical excision margins for non-lentiginous melanoma in situ. Journal of the American Academy of Dermatology. 71: 835-8. PMID 25219711 DOI: 10.1016/j.jaad.2014.06.044  1
2014 Goodman JR, Grossman D. Aspirin and other NSAIDs as chemoprevention agents in melanoma. Cancer Prevention Research (Philadelphia, Pa.). 7: 557-64. PMID 24694780 DOI: 10.1158/1940-6207.CAPR-14-0018  1
2013 King AJ, Gehl RW, Grossman D, Jensen JD. Skin self-examinations and visual identification of atypical nevi: comparing individual and crowdsourcing approaches. Cancer Epidemiology. 37: 979-84. PMID 24075797 DOI: 10.1016/j.canep.2013.09.004  1
2013 McKenzie JA, Liu T, Jung JY, Jones BB, Ekiz HA, Welm AL, Grossman D. Survivin promotion of melanoma metastasis requires upregulation of α5 integrin Carcinogenesis. 34: 2137-2144. PMID 23640047 DOI: 10.1093/carcin/bgt155  1
2013 Jenkins NC, Grossman D. Role of melanin in melanocyte dysregulation of reactive oxygen species Biomed Research International. 2013. PMID 23555101 DOI: 10.1155/2013/908797  1
2013 Grossman D, Bowen GM. Commentary: Transecting melanomas: Does it matter? Dermatologic Surgery. 39: 616-617. PMID 23551555 DOI: 10.1111/dsu.12132  1
2013 Cassidy PB, Fain HD, Cassidy JP, Tran SM, Moos PJ, Boucher KM, Gerads R, Florell SR, Grossman D, Leachman SA. Selenium for the prevention of cutaneous melanoma. Nutrients. 5: 725-49. PMID 23470450 DOI: 10.3390/nu5030725  1
2013 Jenkins NC, Jung J, Liu T, Wilde M, Holmen SL, Grossman D. Familial melanoma-associated mutations in p16 uncouple its tumor-suppressor functions. The Journal of Investigative Dermatology. 133: 1043-51. PMID 23190892 DOI: 10.1038/jid.2012.401  1
2013 Andtbacka RH, Donaldson MR, Bowles TL, Bowen GM, Grossmann K, Khong H, Grossman D, Anker C, Florell SR, Bowen A, Duffy KL, Leachman SA, Noyes RD. Sentinel lymph node biopsy for melanoma in pregnant women. Annals of Surgical Oncology. 20: 689-96. PMID 23054111 DOI: 10.1245/s10434-012-2633-7  1
2012 Duffy K, Grossman D. The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management. Journal of the American Academy of Dermatology. 67: 19.e1-12; quiz 31-2. PMID 22703916 DOI: 10.1016/j.jaad.2012.03.013  1
2012 Duffy K, Grossman D. The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects. Journal of the American Academy of Dermatology. 67: 1.e1-16; quiz 17-8. PMID 22703915 DOI: 10.1016/j.jaad.2012.02.047  1
2012 Mckenzie JA, Grossman D. Role of the apoptotic and mitotic regulator survivin in melanoma Anticancer Research. 32: 397-404. PMID 22287725  1
2011 Goodson AG, Florell SR, Boucher KM, Grossman D. A decade of melanomas: identification of factors associated with delayed detection in an academic group practice. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. 37: 1620-30. PMID 21790849 DOI: 10.1111/j.1524-4725.2011.02097.x  1
2010 McKenzie JA, Liu T, Goodson AG, Grossman D. Survivin enhances motility of melanoma cells by supporting Akt activation and α5 integrin upregulation Cancer Research. 70: 7927-7937. PMID 20807805 DOI: 10.1158/0008-5472.CAN-10-0194  1
2010 Goodson AG, Florell SR, Hyde M, Bowen GM, Grossman D. Comparative analysis of total body and dermatoscopic photographic monitoring of nevi in similar patient populations at risk for cutaneous melanoma. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. 36: 1087-98. PMID 20653722 DOI: 10.1111/j.1524-4725.2010.01589.x  0.44
2010 Goodson AG, Florell SR, Boucher KM, Grossman D. Low rates of clinical recurrence after biopsy of benign to moderately dysplastic melanocytic nevi. Journal of the American Academy of Dermatology. 62: 591-6. PMID 20018406 DOI: 10.1016/j.jaad.2009.06.080  1
2009 Goodson AG, Cotter MA, Cassidy P, Wade M, Florell SR, Liu T, Boucher KM, Grossman D. Use of oral N-acetylcysteine for protection of melanocytic nevi against UV-induced oxidative stress: towards a novel paradigm for melanoma chemoprevention. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 7434-40. PMID 19920101 DOI: 10.1158/1078-0432.CCR-09-1890  1
2009 Goodson AG, Grossman D. Strategies for early melanoma detection: Approaches to the patient with nevi. Journal of the American Academy of Dermatology. 60: 719-35; quiz 736-8. PMID 19389517 DOI: 10.1016/j.jaad.2008.10.065  0.44
2009 LaBarbera DV, Modzelewska K, Glazar AI, Gray PD, Kaur M, Liu T, Grossman D, Harper MK, Kuwada SK, Moghal N, Ireland CM. The marine alkaloid naamidine A promotes caspase-dependent apoptosis in tumor cells. Anti-Cancer Drugs. 20: 425-36. PMID 19369860 DOI: 10.1097/CAD.0b013e32832ae55f  1
2008 Florell SR, Smoller BR, Boucher KM, Grossman D, Harris RM, Bowen GM, Leachman SA. Sampling of melanocytic nevi for research purposes: a prospective, pilot study to determine effect on diagnosis. Journal of the American Academy of Dermatology. 59: 814-21. PMID 19119097 DOI: 10.1016/j.jaad.2008.07.020  1
2008 Florell SR, Meyer LJ, Boucher KM, Grossman D, Cannon-Albright LA, Harris RM, Samlowski WE, Zone JJ, Leachman SA. Increased melanocytic nevi and nevus density in a G-34T CDKN2A/p16 melanoma-prone pedigree. The Journal of Investigative Dermatology. 128: 2122-5. PMID 18337833 DOI: 10.1038/jid.2008.51  1
2008 Raj D, Liu T, Samadashwily G, Li F, Grossman D. Survivin repression by p53, Rb and E2F2 in normal human melanocytes. Carcinogenesis. 29: 194-201. PMID 17916908 DOI: 10.1093/carcin/bgm219  0.44
2007 Cotter MA, Thomas J, Cassidy P, Robinette K, Jenkins N, Florell SR, Leachman S, Samlowski WE, Grossman D. N-acetylcysteine protects melanocytes against oxidative stress/damage and delays onset of ultraviolet-induced melanoma in mice. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 5952-8. PMID 17908992 DOI: 10.1158/1078-0432.CCR-07-1187  1
2007 Thomas J, Liu T, Cotter MA, Florell SR, Robinette K, Hanks AN, Grossman D. Melanocyte expression of survivin promotes development and metastasis of UV-induced melanoma in HGF-transgenic mice. Cancer Research. 67: 5172-8. PMID 17545596 DOI: 10.1158/0008-5472.CAN-06-3669  1
2007 Cotter MA, Florell SR, Leachman SA, Grossman D. Absence of senescence-associated beta-galactosidase activity in human melanocytic nevi in vivo. The Journal of Investigative Dermatology. 127: 2469-71. PMID 17522702 DOI: 10.1038/sj.jid.5700903  1
2006 Yan H, Brouha B, Liu T, Raj D, Biddle D, Lee R, Grossman D. Proteolytic cleavage of Livin (ML-IAP) in apoptotic melanoma cells potentially mediated by a non-canonical caspase. Journal of Dermatological Science. 43: 189-200. PMID 16806840 DOI: 10.1016/j.jdermsci.2006.05.007  0.44
2006 Liu T, Biddle D, Hanks AN, Brouha B, Yan H, Lee RM, Leachman SA, Grossman D. Activation of dual apoptotic pathways in human melanocytes and protection by survivin. The Journal of Investigative Dermatology. 126: 2247-56. PMID 16728972 DOI: 10.1038/sj.jid.5700381  0.44
2005 Florell SR, Meyer LJ, Boucher KM, Hart M, Cannon-Albright LA, Harris RM, Grossman D, Samlowski WE, Zone JJ, Brinton JP, Leachman SA. Nevus distribution in a Utah melanoma kindred with a temperature-sensitive CDKN2A mutation. The Journal of Investigative Dermatology. 125: 1310-2. PMID 16354203 DOI: 10.1111/j.0022-202X.2005.23945.x  1
2005 Zhang W, Hanks AN, Boucher K, Florell SR, Allen SM, Alexander A, Brash DE, Grossman D. UVB-induced apoptosis drives clonal expansion during skin tumor development. Carcinogenesis. 26: 249-57. PMID 15498793 DOI: 10.1093/carcin/bgh300  1
2004 Alexander A, Harris RM, Grossman D, Bruggers CS, Leachman SA. Vulvar melanoma: diffuse melanosis and metastasis to the placenta. Journal of the American Academy of Dermatology. 50: 293-8. PMID 14726891 DOI: 10.1016/j.jaad.2003.07.009  1
2004 Liu T, Brouha B, Grossman D. Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells. Oncogene. 23: 39-48. PMID 14712209 DOI: 10.1038/sj.onc.1206978  0.44
2003 Florell SR, Schmidt SJ, Porter-Gill P, Albertine KH, Murphy KJ, McKinney CB, Boucher KM, Grossman D, Biddle DL, Clayton F, Layfield LJ, Leachman SA. Novel application of a fibrin cell block method to evaluate melanocytic cell populations. Pigment Cell Research / Sponsored by the European Society For Pigment Cell Research and the International Pigment Cell Society. 16: 662-9. PMID 14629724 DOI: 10.1046/j.1600-0749.2003.00095.x  1
2003 Liu J, Dai Q, Chen J, Durrant D, Freeman A, Liu T, Grossman D, Lee RM. Phospholipid scramblase 3 controls mitochondrial structure, function, and apoptotic response. Molecular Cancer Research : McR. 1: 892-902. PMID 14573790  0.44
Show low-probability matches.